Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data2018 · 61 citations
2. 2A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of <i>Pseudomonas aeruginosa</i> Infections2020 · 43 citations
3. 3Risk Factors for Carbapenem-Resistant<i>Pseudomonas aeruginosa</i>, Zhejiang Province, China2019 · 54 citations
4. 4Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update2020 · 378 citations
5. 5Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> at US Emerging Infections Program Sites, 20152019 · 115 citations